| ASSET | QUARTER | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | Q1 2020 | 5.82% |
Eli Lilly and (LLY) | Q2 2020 | 23.1% |
Eli Lilly and (LLY) | Q3 2020 | -9.48% |
Eli Lilly and (LLY) | Q4 2020 | 14.4% |
Eli Lilly and (LLY) | Q1 2021 | 10.99% |
Eli Lilly and (LLY) | Q2 2021 | 23.4% |
Eli Lilly and (LLY) | Q3 2021 | 1% |
Eli Lilly and (LLY) | Q4 2021 | 19.96% |
Eli Lilly and (LLY) | Q1 2022 | 4.79% |
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Eli Lilly and (LLY) | Q3 2022 | 0.16% |
Eli Lilly and (LLY) | Q4 2022 | 12.52% |
Eli Lilly and (LLY) | Q1 2023 | -5.93% |
Eli Lilly and (LLY) | Q2 2023 | 36.99% |
Eli Lilly and (LLY) | Q3 2023 | 15.45% |
Eli Lilly and (LLY) | Q4 2023 | 8.95% |
Eli Lilly and (LLY) | Q1 2024 | 34.27% |
Eli Lilly and (LLY) | Q2 2024 | 16.87% |
Eli Lilly and (LLY) | Q3 2024 | -2.7% |
Eli Lilly and (LLY) | Q4 2024 | -13% |
Eli Lilly and (LLY) | Q1 2025 | 5.99% |
Eli Lilly and (LLY) | Q2 2025 | -4.58% |
Eli Lilly and (LLY) | Q3 2025 | -1.91% |
Eli Lilly and (LLY) | Q4 2025 | 41% |
Eli Lilly and (LLY) | Q1 2026 | 0.2% |
